Categories
- Global News Feed
- Uncategorized
- Alabama Stem Cells
- Alaska Stem Cells
- Arkansas Stem Cells
- Arizona Stem Cells
- California Stem Cells
- Colorado Stem Cells
- Connecticut Stem Cells
- Delaware Stem Cells
- Florida Stem Cells
- Georgia Stem Cells
- Hawaii Stem Cells
- Idaho Stem Cells
- Illinois Stem Cells
- Indiana Stem Cells
- Iowa Stem Cells
- Kansas Stem Cells
- Kentucky Stem Cells
- Louisiana Stem Cells
- Maine Stem Cells
- Maryland Stem Cells
- Massachusetts Stem Cells
- Michigan Stem Cells
- Minnesota Stem Cells
- Mississippi Stem Cells
- Missouri Stem Cells
- Montana Stem Cells
- Nebraska Stem Cells
- New Hampshire Stem Cells
- New Jersey Stem Cells
- New Mexico Stem Cells
- New York Stem Cells
- Nevada Stem Cells
- North Carolina Stem Cells
- North Dakota Stem Cells
- Oklahoma Stem Cells
- Ohio Stem Cells
- Oregon Stem Cells
- Pennsylvania Stem Cells
- Rhode Island Stem Cells
- South Carolina Stem Cells
- South Dakota Stem Cells
- Tennessee Stem Cells
- Texas Stem Cells
- Utah Stem Cells
- Vermont Stem Cells
- Virginia Stem Cells
- Washington Stem Cells
- West Virginia Stem Cells
- Wisconsin Stem Cells
- Wyoming Stem Cells
- Biotechnology
- Cell Medicine
- Cell Therapy
- Diabetes
- Epigenetics
- Gene therapy
- Genetics
- Genetic Engineering
- Genetic medicine
- HCG Diet
- Hormone Replacement Therapy
- Human Genetics
- Integrative Medicine
- Molecular Genetics
- Molecular Medicine
- Nano medicine
- Preventative Medicine
- Regenerative Medicine
- Stem Cells
- Stell Cell Genetics
- Stem Cell Research
- Stem Cell Treatments
- Stem Cell Therapy
- Stem Cell Videos
- Testosterone Replacement Therapy
- Testosterone Shots
- Transhumanism
- Transhumanist
Archives
Recommended Sites
Monthly Archives: January 2013
Stem Cell Facial Treatment Video – Video
Posted: January 29, 2013 at 9:49 pm
Stem Cell Facial Treatment Video
where-do-you-get-stem-cells-for-a-stem-cell-face-lift-with-robert-brueck-md
By: AHJCosmeticSkinCare
Read the original:
Stem Cell Facial Treatment Video - Video
Posted in Stem Cell Videos
Comments Off on Stem Cell Facial Treatment Video – Video
Who Needs to Know About Biotechnology, Nanotechnology or Stem Cell Research? (2012) – Video
Posted: January 29, 2013 at 9:49 pm
Who Needs to Know About Biotechnology, Nanotechnology or Stem Cell Research? (2012)
Dominique Brossard, PhD, Professor of Life Sciences Communications, University of Wisconsin
By: franklinsociety
See original here:
Who Needs to Know About Biotechnology, Nanotechnology or Stem Cell Research? (2012) - Video
Posted in Stem Cell Research
Comments Off on Who Needs to Know About Biotechnology, Nanotechnology or Stem Cell Research? (2012) – Video
US Supreme Courts Allows Stem Cell Research to Continue: Dr. Curt Civin Explains the Impact – Video
Posted: January 29, 2013 at 9:49 pm
US Supreme Courts Allows Stem Cell Research to Continue: Dr. Curt Civin Explains the Impact
The USSupreme Court will not hear an appeal from two scientists who challenged federal funding of embryonic stem cell research. The decision leaves in place President Obama #39;s 2009 executive order expanding research on stem cells taken from human embryos, which many scientists say has the potential to produce breakthroughs in treatment of numerous conditions. Dr. Curt Civin is director of the Center for Stem Cell Biology and Regenerative Medicine at the University of Maryland School of Medicine. In this video, Dr. Civin explains the impact. Learn more about Stem Cell Research at the University of Maryland School of Medicine: medschool.umaryland.edu Learn More about the Dickey-Wicker Amendment: en.wikipedia.org
By: schoolofmedicine
See more here:
US Supreme Courts Allows Stem Cell Research to Continue: Dr. Curt Civin Explains the Impact - Video
Posted in Stem Cell Research
Comments Off on US Supreme Courts Allows Stem Cell Research to Continue: Dr. Curt Civin Explains the Impact – Video
The TRUE Conservative Republican Position on Embryonic Stem Cell Research – Video
Posted: January 29, 2013 at 9:49 pm
The TRUE Conservative Republican Position on Embryonic Stem Cell Research
Senator (Dr.) Bill Frist explains (in great detail) how George W. Bush, and Conservatives in general ABSOLUTELY support Federal Funding for Stem Cell Research. He also explains some of the misconceptions regarding how Stem Cells work, and what we can expect in terms of actual therapy as this research progresses. This video is from 2004 but the Conservative viewpoint remains essentially the same.
By: dajiban
Visit link:
The TRUE Conservative Republican Position on Embryonic Stem Cell Research - Video
Posted in Stem Cell Research
Comments Off on The TRUE Conservative Republican Position on Embryonic Stem Cell Research – Video
Stem Cell Research: Stem Cells Nearly Cure Rats of Stroke Complications
Posted: January 29, 2013 at 4:48 pm
The latest in stem cell research suggests that stem cells given in the vital period immediately after a stroke (known colloquially as the "golden hour") could make major headway in recovery. A research team in Bolivia injected rats with stem cells thirty minutes after a stroke, and discovered that they had almost completely normal brain function restored within two weeks. The team says that this has serious potential in human trials. Their study was led by Dr. Exuperio Diez-Tejedor from La Paz University Hospital, and supports previous studies that point in a similar direction: stem cells can be useful in treating stroke patients because they aid the body's ability to repair tissue damage. The stem cells used in this study were multipotent stromal cells extracted from fat and bone marrow. These are the types of stem cells that people are talking about when they talk of "master cells," the kind that can differentiate into many different cell types. Researchers hope that they will ultimately replace cells that are lost through disease or injury. The Bolivian study was published in the open-access journal Stem Cell Research and Therapy.
The controversy surrounding stem cells, at least in the United States, has been primarily centered around embryonic stem cells; but in this study, Dr. Diez-Tejedor was able to use "allogenic" (foreign) cells from other rats, and stated: "Improved recovery was seen regardless of origin of the stem cells, which may increase the usefulness of this treatment in human trials. Adipose (fat)-derived cells in particular are abundant and easy to collect without invasive surgery." This is outstanding news, as it implies that further research can be done and treatments be created without the destruction of embryos, effectively removing the politics from this branch of medicine. The team seems incredibly optimistic about their results, stating that they believe they might even be able to stop the "chain reaction" of cellular damage that results when the initial injury destroys cells in the surrounding areas. They continued, "From the viewpoint of clinical translation allogenic stem cells are attractive because they can be easily obtained from young healthy donors, amplified, and stored for immediate use when needed after a stroke." This implies that the usage of adult stem cells collected in a similar manner to that of a blood drive could ultimately provide a stroke treatment that would be immediately available to a suffering patient, just like donor blood. As exciting as this is, Dr. Clare Walton of the British organization The Stroke Association put a gentle damper on the enthusiasm, telling BBC News that human trials will not be happening anytime soon: "Stem cells are an incredibly interesting area of stroke research and the results of this study provide further insight into their potential use for stroke recovery. However, we are a long way off these types of treatments being used in humans and a lot more research is needed."
Despite the payoff of studies such as this one being so far in the future, the data suggesting that adult stem cells could be so incredibly useful should be heartening for those who have been disappointed by the political interference in this branch of medical research to date.
Follow Lauren Moccio on Twitter @TheGrottoTweets for more commentary on news, entertainment & politics.
You have successfully submitted a report for this post.
Read the original post:
Stem Cell Research: Stem Cells Nearly Cure Rats of Stroke Complications
Posted in Stem Cells
Comments Off on Stem Cell Research: Stem Cells Nearly Cure Rats of Stroke Complications
Stem cells aid recovery from stroke, study suggests
Posted: January 29, 2013 at 4:48 pm
Jan. 28, 2013 Stem cells from bone marrow or fat improve recovery after stroke in rats, finds a study published in BioMed Central's open access journal Stem Cell Research & Therapy. Treatment with stem cells improved the amount of brain and nerve repair and the ability of the animals to complete behavioural tasks.
Stem cell therapy holds promise for patients but there are many questions which need to be answered, regarding treatment protocols and which cell types to use. This research attempts to address some of these questions.
Rats were treated intravenously with stem cells or saline 30 minutes after a stroke. At 24 hours after stroke the stem cell treated rats showed a better functional recovery. By two weeks these animals had near normal scores in the tests. This improvement was seen even though the stem cells did not appear to migrate to the damaged area of brain. The treated rats also had higher levels of biomarkers implicated in brain repair including, the growth factor VEGF.
A positive result was seen for both fat (adipose) and bone-marrow derived stem cells. Dr Exuperio Dez-Tejedor from La Paz University Hospital, explained, "Improved recovery was seen regardless of origin of the stem cells, which may increase the usefulness of this treatment in human trials. Adipose-derived cells in particular are abundant and easy to collect without invasive surgery."
Share this story on Facebook, Twitter, and Google:
Other social bookmarking and sharing tools:
Story Source:
The above story is reprinted from materials provided by BioMed Central Limited.
Note: Materials may be edited for content and length. For further information, please contact the source cited above.
Journal Reference:
Read the original here:
Stem cells aid recovery from stroke, study suggests
Posted in Stem Cells
Comments Off on Stem cells aid recovery from stroke, study suggests
Stroke Recovery Aided by Stem Cells, Study Shows
Posted: January 29, 2013 at 4:48 pm
A new study has shown that stem cells may aid recovery in rats that have suffered a stroke. The study, published in the journal Stem Cell Research & Therapy, found that stem cell treatments improved the amount of brain and nerve tissue that was repaired and increased the ability of the rats to complete behavioral tasks. Researchers used stem cells from both bone-marrow and fat tissue, and found positive results for each.
Improved recovery was seen regardless of origin of the stem cells, which may increase the usefulness of this treatment in human trials, said Dr. Exuperio Dez-Tejedor, principal investigator in the neurology department at La Paz University Hospital. Adipose-derived cells in particular are abundant and easy to collect without invasive surgery.
Though this type of research is promising for human patients, the researchers stated that questions regarding treatment protocols and which types of stem cells to use still need to be answered.
The rats in the study were injected with stem cells or saline 30 minutes after suffering a stroke. 24 hours after the stroke, the rats treated with stem cells had already shown a better recovery. Two weeks later the stem cell-treated rats had nearly normal scores on their behavioral tests.
The rats that received stem cells were also found to have higher levels of biomarkers linked to brain repair. This is despite of the fact that the stem cells did not appear to migrate to the damaged area of the brain.
See original here:
Stroke Recovery Aided by Stem Cells, Study Shows
Posted in Stem Cells
Comments Off on Stroke Recovery Aided by Stem Cells, Study Shows
ReNeuron Group edges further in stem cell therapy research for stroke patients
Posted: January 29, 2013 at 4:44 pm
LONDON (ShareCast) - ReNeuron Group received the green light to complete the final stages of first phase safety testing of its ReN001 stem cell therapy for disabled stroke patients in Scotland, the company announced Tuesday.
The ReN001 stem cell therapy was being administered in ascending doses to a total of 12 stroke patients who have been left disabled by an ischaemic stroke, the most common form of the condition.
ReNeuron is now set to proceed with dosing the last three patients after getting clearance from the Data Safety Monitoring Board which reviewed the study.
The first of the three patients was treated with ReN001 and discharged from hospital. The remaining two are scheduled to be treated this March.
Last year, interim data from the first five patients treated in the study were presented by the Glasgow clinical team. Sustained reductions in neurological impairment and spasticity were observed in all patients compared with their stable pre-treatment baseline performance.
Further and longer term data from the study are expected to be presented in scientific conference later this year.
The company has submitted an application to the UK regulatory authority to commence a multi-site phase two clinical trial to examine the efficacy of ReN001 in patients disabled by an ischaemic stroke. Preparations are underway to begin the trial mid-year.
RD
Read more from the original source:
ReNeuron Group edges further in stem cell therapy research for stroke patients
Posted in Stem Cell Therapy
Comments Off on ReNeuron Group edges further in stem cell therapy research for stroke patients
Stem Cell Therapy Helps Stroke Victims Recover in Two Weeks
Posted: January 29, 2013 at 4:44 pm
The rats completely recovered from a stroke within two weeks with stem cell therapy (Wiki Commons)
Stem cell therapy administered shortly after a stroke could significantly increase the sufferer's chance of a complete recovery.
When administered to rats within 30 minutes of suffering a stroke, the rodents made a full recovery within two weeks, a study showed.
The research, published in BioMed Central's open access journalStem Cell Research & Therapy, found that stem cells from the bone marrow of fat can improve the recovery of rats following a stroke.
Researchers at La Paz University Hospital found that treatment improved the amount of brain and nerve repair, as well as the animal's ability to complete tasks.
Rats were treated intravenously with stem cells half an hour after a stroke. In humans, such rapid response is known to dramatically improve the outcome of victims.
The researchers found improvements in the stem cell group within 24 hours of the treatment, compared to the control group.
The FAST response advertising campaign has aimed to increase awareness of symptoms. Facial and arm weakness and speech problems suggest it is time to call emergency services.
Human trials
A delay in treatment can result in death or long-term disabilities. A stroke occurs when the blood supply to part of the brain is cut off.
Link:
Stem Cell Therapy Helps Stroke Victims Recover in Two Weeks
Posted in Stem Cell Therapy
Comments Off on Stem Cell Therapy Helps Stroke Victims Recover in Two Weeks
CIRM's Thomas: Conflicts 'Put to Bed' at Stem Cell Agency
Posted: January 29, 2013 at 1:50 am
The chairman of the $3 billion
California stem cell agency, Jonathan Thomas, today hailed board
action last week as putting “to bed once and for all” questions
about financial conflicts of interest by members of the agency's
governing board.
Writing on the agency's blog, Thomas
pointed to board approval of a new policy that would bar 13 of the 29
members of the governing board from voting on any grants whatsoever.
The 13 are the members who are “appointed from an institution that
is eligible to receive money.” Three other board members have ties
to institutions that receive money. Two are employees of the institutions and one is the
chair of the University of California board of regents, Sherry
Lansing. All three are appointed as patient advocate members of the
board. Currently all 16 are barred individually from voting on grants
to their institutions, but they can vote for awards to other
institutions.
pointed to board approval of a new policy that would bar 13 of the 29
members of the governing board from voting on any grants whatsoever.
The 13 are the members who are “appointed from an institution that
is eligible to receive money.” Three other board members have ties
to institutions that receive money. Two are employees of the institutions and one is the
chair of the University of California board of regents, Sherry
Lansing. All three are appointed as patient advocate members of the
board. Currently all 16 are barred individually from voting on grants
to their institutions, but they can vote for awards to other
institutions.
Thomas proposed the plan last week to
the governing board, which approved it on a 23-0 vote with one
abstention. Thomas advanced the proposal in response to the
recommendations of a 17-month study by the Institute of Medicine(IOM).
CIRM paid $700,000 for the blue-ribbon report, hoping that it would
serve as the basis for continued financing of the agency beyond 2017,
when funds for new grants run out.
the governing board, which approved it on a 23-0 vote with one
abstention. Thomas advanced the proposal in response to the
recommendations of a 17-month study by the Institute of Medicine(IOM).
CIRM paid $700,000 for the blue-ribbon report, hoping that it would
serve as the basis for continued financing of the agency beyond 2017,
when funds for new grants run out.
The IOM's far-reaching recommendations
included creation of a majority of independent members on the board,
which would mean some current members of the board would lose their
seats. No institutions would be guaranteed seats on the board.
Currently five members are appointed from the University of
California. The Thomas plan does not deal with those recommendations.
included creation of a majority of independent members on the board,
which would mean some current members of the board would lose their
seats. No institutions would be guaranteed seats on the board.
Currently five members are appointed from the University of
California. The Thomas plan does not deal with those recommendations.
The IOM said “far too many” members
of the board have ties to institutions that receive funds from CIRM.
Compilations by the California Stem Cell Report show that about 90
percent of the $1.7 billion that the board has awarded has gone to
institutions linked to directors.
of the board have ties to institutions that receive funds from CIRM.
Compilations by the California Stem Cell Report show that about 90
percent of the $1.7 billion that the board has awarded has gone to
institutions linked to directors.
Thomas said that the board last week
“endorsed a framework of proposals that would dramatically change
the way the board works, and directly addresses the concerns and
recommendations of the IOM, in particular their feeling that the way
our Board works could create a perception of conflict of interest.”
“endorsed a framework of proposals that would dramatically change
the way the board works, and directly addresses the concerns and
recommendations of the IOM, in particular their feeling that the way
our Board works could create a perception of conflict of interest.”
Concerning the change in voting for the
13 board members, Thomas wrote,
13 board members, Thomas wrote,
“It was not an easy change to propose
and certainly not an easy one for our board members to approve. They
all care deeply about our mission and devote a great deal of thought,
time and energy to helping us do our work. So for 13 of them to agree
to abstain from a key aspect of their work was difficult to say the
least. And yet they did it because they felt it was important for the
overall goal of the agency.”
Thomas continued,
“So why did we take this approach?
It's simple. We want people to focus on the great work we do, on the
groundbreaking research we fund, and the impact we are having on the
field of regenerative medicine not just in California but throughout
the U.S. and around the world. As long as there are perceptions of
conflict of interest hanging over the Board, this will continue to be
difficult.”
Thomas said,
“This puts the economic conflicts
issue to bed once and for all.”
Posted in Stem Cells, Stem Cell Therapy
Comments Off on CIRM's Thomas: Conflicts 'Put to Bed' at Stem Cell Agency